DRDO’S Covid-19 Drug 2-DG Approved by the DCGI of India.

256 Views

The good news in this pandemic that DRDO made an anti-Covid-19 drug, name 2-deoxy-D-glucose (2-DG). It is approved by the Drugs Controller General of India on 9th May. It can be used only for moderate and severe patients. It can minimize the dependency on Oxygen. Through this article, we are going to discuss all the related information about Covid -19 anti-drug.

DRDO’S Covid-19 Drug, 2-DG:-

This drug Deoxy-D-glucose has developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS). This is the lab of Defence Research and Development Organisation (DRDO) and this medicine is developed with the collaboration with Dr. Reddy’s Laboratories, Hyderabad.

DRDO Anti Covid Drug:-

When the first phase of coronavirus surge in the country then the DRDO scientist start developing an anti covid drug in INMAS with the collaboration of CCMB – Centre for Cellular and Molecular Biology in Hyderabad. They found that the 2-DG molecule works better against the SARS-CoV-2 virus and stops the growth of the virus in the lungs. After this result, the DCGI of India give the permission of phase-2 trail.

New weapons of Defence that under trial in DRDO

During the phase-II trial, they found that the drug is safe for the corona patient. The DRDO 2DG medicine phase-II and phase-IIb trials were conducted in 6 and 11 hospitals respectively across the nation.

After receiving positive responses in Phase-II and Phase-IIb trials, DCGI permitted phase-III trials. A total of 220 patients included in the phase-3 trial and these patients were from 27 Covid-1 Hospitals of UP, West Bengal, Gujarat, Delhi, Maharashtra, Telangana, Rajasthan, Tamilnadu, and Karnataka. The majority of the patients showed improvements and became independent from supplemental oxygen by Day 3.

After the 3rd trial result, DRDO’S Covid-19 Drug 2-DG Approved by the DCGI of India on 9th May 2021 for the moderate and severe patient of covid-19. It can help that patient who is totally dependent on Oxygen.

This drug approved at a very crucial time where India suffering from a lack of Oxygen and beds in the hospitals. So this is good news for all the defence aspirants too who want to join the classroom programs at the MKC campus.

You can Avail our Service:-

For purchasing any books for defence examination- Click Here

For Joining Test Series- Click Here

For Online Course at MKC Learning App- Click Here

Visit our YouTube Channel For Free Education:- Click Here

This is all about the DRDO’S Covid-19 Drug 2-DG Approved by the DCGI of India. If you guys want to serve the nation and want to clear the Defence examination, join Major Kalshi Classes, Here we have experienced faculty for all the subjects. For more inquiries, you can call us at 9696220022 and 9696330033 or go to our official website www.majorkalshiclasses.com. Thank you.

FOLLOW
Leave a comment